Myriad Genetics · 16 hours ago
Product Manager II Technology - EMR
Myriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being. The Product Manager II Technology role will drive the expansion and adoption of genetic tests by enhancing EMR integrations with health systems and vendors.
BiotechnologyPharmaceuticalPrecision Medicine
Responsibilities
Drive prioritization efforts for the EMR product domain
Partner with PMO, TPMs, and business stakeholders to write crisp and clear product requirements that drive technical specifications and user experience and interface designs
Engage with UX designers, business stakeholders, and software engineering teams through the full product and order management lifecycle
Manage and maintain the backlog of the engineering team(s) you are assigned to. This includes prioritization, requirements refinement, quarterly planning, and Jira hygiene standards
Champion our EMR products throughout the organization and present updates to senior management
Continually validate products with internal and external customer feedback and against business metrics
Qualification
Required
Minimum of 3 years of Product Owner experience with proven success shipping multiple technology products across releases
Strong leadership skills and proven ability to lead cross-functional teams
Track record of understanding customer needs and delivering technology solutions to address those needs
Experience developing and presenting business cases and multi-phase product roadmaps
Strong analytical problem-solving and data-driven approach to decision making
Exceptional verbal and written communication skills
Attention to detail
Proficient in Agile development
Applicant must be a (i) U.S. citizen or national, (ii) U.S. lawful, permanent resident (aka green card holder)
Preferred
Bachelor's degree in a relevant field preferred
CSPO certification is preferred but not required
Knowledge of the healthcare space preferred
Company
Myriad Genetics
Myriad Genetics discovers, develops, and commercializing novel therapies for the treatment of cancer.
Funding
Current Stage
Public CompanyTotal Funding
$215MKey Investors
OrbiMed
2025-07-31Post Ipo Debt· $125M
2023-07-06Post Ipo Debt· $90M
1995-10-13IPO
Recent News
Company data provided by crunchbase